S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
Log in

OrganiGram Stock Price, Forecast & Analysis (NASDAQ:OGI)

$2.47
-0.04 (-1.59 %)
(As of 11/14/2019 04:00 PM ET)
Today's Range
$2.29
Now: $2.47
$2.57
50-Day Range
$2.48
MA: $3.43
$3.86
52-Week Range
$2.29
Now: $2.47
$8.44
Volume4.29 million shs
Average Volume1.17 million shs
Market Capitalization$385.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OrganiGram Holdings Inc., through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OGI
CUSIPN/A
CIKN/A
Phone844-644-4726

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.73 million

Profitability

Miscellaneous

Employees615
Market Cap$385.76 million
Next Earnings Date11/25/2019 (Confirmed)
OptionableNot Optionable

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.


OrganiGram (NASDAQ:OGI) Frequently Asked Questions

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc (NASDAQ:OGI) issued its earnings results on Monday, July, 15th. The company reported ($0.07) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.02 by $0.09. The business earned $30.36 million during the quarter, compared to analyst estimates of $30.81 million. The firm's revenue for the quarter was up 782.6% on a year-over-year basis. View OrganiGram's Earnings History.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release their next quarterly earnings announcement on Monday, November 25th 2019. View Earnings Estimates for OrganiGram.

What price target have analysts set for OGI?

7 equities research analysts have issued 12 month price targets for OrganiGram's shares. Their forecasts range from $8.20 to $17.10. On average, they anticipate OrganiGram's stock price to reach $10.96 in the next year. This suggests a possible upside of 343.7% from the stock's current price. View Analyst Price Targets for OrganiGram.

What is the consensus analysts' recommendation for OrganiGram?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OrganiGram.

Has OrganiGram been receiving favorable news coverage?

News stories about OGI stock have been trending somewhat negative recently, InfoTrie reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. OrganiGram earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for OrganiGram.

Are investors shorting OrganiGram?

OrganiGram saw a increase in short interest in the month of October. As of October 15th, there was short interest totalling 4,280,000 shares, an increase of 46.1% from the September 15th total of 2,930,000 shares. Based on an average daily volume of 1,300,000 shares, the short-interest ratio is presently 3.3 days. Currently, 2.9% of the shares of the stock are short sold. View OrganiGram's Current Options Chain.

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), KushCo (KSHB), Aphria (APHA), Charlotte's Web (CWBHF), HEXO (HEXO), Innovative Industrial Properties (IIPR), Alibaba Group (BABA) and NVIDIA (NVDA).

Who are OrganiGram's key executives?

OrganiGram's management team includes the folowing people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Peter R. Hanson, Director of Fin.

Who are OrganiGram's major shareholders?

OrganiGram's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Commonwealth Equity Services LLC (0.06%), Sigma Planning Corp (0.04%), Cambridge Investment Research Advisors Inc. (0.02%), Traynor Capital Management Inc. (0.02%), Signition LP (0.02%) and Sfmg LLC (0.02%).

Which major investors are buying OrganiGram stock?

OGI stock was bought by a variety of institutional investors in the last quarter, including Sigma Planning Corp, Cambridge Investment Research Advisors Inc., Signition LP, Archford Capital Strategies LLC, Wedbush Securities Inc., Commonwealth Equity Services LLC, Traynor Capital Management Inc. and Sfmg LLC.

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $2.47.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of $385.76 million and generates $9.73 million in revenue each year. OrganiGram employs 615 workers across the globe.View Additional Information About OrganiGram.

What is OrganiGram's official website?

The official website for OrganiGram is http://www.organigram.ca/.

How can I contact OrganiGram?

OrganiGram's mailing address is 35A ENGLISH DR., MONCTON A3, E1E 3X3. The company can be reached via phone at 844-644-4726.


MarketBeat Community Rating for OrganiGram (NASDAQ OGI)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  176
MarketBeat's community ratings are surveys of what our community members think about OrganiGram and other stocks. Vote "Outperform" if you believe OGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel